📰 Mark Diagnostics News
Page 3 - Mark Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Diagnostics. Real-time updates on events, politics, business and more.
February 15, 2023
Molecular Diagnostics Market study by "Data Bridge Market Research" provides details about the market dynamics affecting this market, Market scope, Market
February 7, 2023
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company
January 11, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 11, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced stage liquid biopsy company
December 12, 2022
The rising incidence of infectious bacterial and viral diseases impacts the market's demand because, in the syndromic testing, multiplex real-time PCR...
December 9, 2022
/PRNewswire/ -- Major players in the clinical chemistry market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITech Group, Beckman Coulter Inc., Thermo...
October 25, 2022
Market Study on Molecular Diagnostics in Infectious Disease Testing: North America to Continue Leading Global Market Growth...
September 8, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced stage liquid biopsy company with a focus on
September 1, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an oncology-focused company with advanced near-to-market
August 30, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an oncology-focused company with advanced
July 16, 2022
(2022-07-14 | CSE:BUX) BioMark Provides Financial Results for the Year Ended March 31, 2022, and Recent Corporate Highlights